BioCentury
ARTICLE | Clinical News

Neutralase heparin degrading enzyme: Phase II

September 30, 1996 7:00 AM UTC

Ibex Technologies Inc. (TSE:IBT), Montreal, Quebec Product: Neutralase heparin degrading enzyme (heparinase I) Use: Replace protamine as a heparin neutralizer after cardiac bypass surgery Status: IBT ...